Product photo · 70mg
Reports describe submitted samples for this amount and form.
GLOW Blend
GLOW combines GHK-Cu, BPC-157 and TB-500 in a 70mg blend.
What does the amount mean?
10 mg is an amount of material. Read the label to see whether it means per vial, per tablet, or per package.
Read more1 vial · 70mg in each vial
You can add this product to your cart. Checkout is temporarily unavailable.
Lab resultsGLOW Blend, explained
GLOW combines GHK-Cu, BPC-157 and TB-500 in a 70mg blend.
What it’s used for
GLOW combines GHK-Cu, BPC-157 and TB-500 in a 70mg peptide blend, bringing ingredients from copper-peptide and connective-tissue research into one vial format.
GLOW Blend combines GHK-Cu, BPC-157 and TB-500 in a vial labeled 70mg total. GHK-Cu is a copper-binding peptide studied in skin-matrix research. BPC-157 is studied for cell movement and signaling in connective-tissue repair models.
Those named components, together with TB-500, define the three-peptide blend. The 70mg label is the combined amount across the formula.
- Research interests
- Skin · Recovery · Three-peptide blend
Contains multiple peptides; the combined formula has not been proven in people.
- Owner-confirmed ingredients
- GHK-Cu · BPC-157 · TB-500
Individual ingredient amounts have not been supplied.
Side effects & safety
Contains multiple peptides; the combined formula has not been proven in people.
What the evidence covers
Named molecule in the cited setting; not independent testing of Monroe stock.
Exact formulation matters
Studies of one ingredient do not establish the effects or safety of the combined formulation.
Sample testing and human safety
A sample's purity, content or endotoxin report answers a different question from clinical safety. It does not establish the safety or suitability of this product for a person.
How much people usually take
The labelled amount of GLOW Blend describes the listing quantity, not a personal dose.
No direct human studies verified. Contains multiple peptides; the combined formula has not been proven in people. Trial amounts, schedules and monitoring belong to the specific study formulation and population; they cannot be converted into instructions for this listing.
A usual amount is not reported in the linked sources.
How to mix and store it
GLOW Blend is a combined formulation, so its ingredients need separate attention.
A total label amount does not identify the amount of each ingredient. No formula-specific solvent, final volume, stability period or compatibility instructions are supplied here.
- Recorded presentation
- Vial
Combining it with others
GLOW Blend already combines named materials; component research is not evidence for the mixture.
The recorded ingredients are GHK-Cu, BPC-157, TB-500. Individual-ingredient findings do not establish combined behavior, stability or interaction risk; unspecified component quantities remain unknown.
What the research says
No direct human studies verified. Named molecule in the cited setting; not independent testing of Monroe stock.
These selected sources support the stated mechanism or research setting. They are not a systematic review, a test of Monroe inventory or an independent assessment of the finished product.
Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing
BPC-157 connective-tissue repair-model research; no effect is assigned to the whole blend.
GHK-Cu matrix research
Copper-peptide matrix research context only.
Lab results
70mg · 1 linked report
- Amount found · BPC-157
- Sample 1: 12.62 mgSample 2: 12.45 mgSample 3: 12.4 mg
- Amount found · TB-500 (TB4)
- Sample 1: 11.28 mgSample 2: 11.12 mgSample 3: 11.05 mg
- Amount found · GHK-Cu
- Sample 1: 64.36 mgSample 2: 63.6 mgSample 3: 63.42 mg
- Amount found · GHK content
- Sample 1: 56.82 mgSample 2: 56.14 mgSample 3: 56.03 mg
- Amount found · Copper content
- Sample 1: 7.54 mgSample 2: 7.46 mgSample 3: 7.39 mg
Separate sample results, in report order.
Purity & amount
Sample batch GL006
These are submitted-sample results, separate from general research or popularity ratings. Report presentation: Peptify Analytics. Source laboratory: Janoshik Analytical. The connection to the batch you would receive is not confirmed here.
Videos worth watching
Research conversations, with their original context.
Video resources are not available for this guide.
Read the original sourcesProduct details
- Form
- Vial
- Amount
- 70mg
Sources & further reading
Follow each reference to its original publication or documentation.
- Primary researchGHK-Cu matrix research (opens in a new tab)
Questions
What does 70mg mean?
It describes an amount of material in the unit stated on the label. It does not describe liquid volume, a dose, or how to prepare the product.
Read more about amountsDoes purity mean it is sterile?
No. Purity and sterility require different tests. An endotoxin result also does not establish sterility.
About testingHow can I get help with an order?
Open your order details to check its current status. Shipping and support information are available below.
Contact usMore to explore
Shop allBPC-157 / TB-500 Blend
BPC-157 / TB-500 Blend brings two named research peptides into one product, with BPC-157 linked to connective-tissue studies and TB-500 to thymosin-beta-4 research.
Research material · Vial
6mg/6mg · 10mg/10mg
Brain Blend
Brain Blend combines Selank and Semax in one 6mg/6mg peptide blend, bringing together two distinct approaches to neurotransmitter and nerve-cell signaling research.
Research material · Vial
6mg/6mg
CJC-1295 no DAC + Ipamorelin Blend
CJC-1295 no DAC + Ipamorelin Blend combines two named peptides from growth hormone-signaling research: the GHRH category and the ghrelin-receptor secretagogue category.
Blended Peptides
CJC-1295 no DAC + Ipamorelin Blend
KLOW Blend
KLOW combines KPV, GHK-Cu, TB-500 and BPC-157 in an 80mg peptide blend, adding an inflammatory-signaling research component to the four-peptide formula.
Research material · Vial
80mg